Sigrid Therapeutics Announces First Patient Treated with SiPore21® Medical Device for Sustained Diabetes and Obesity Control ...Middle East

PR Newswire - News
Sigrid Therapeutics Announces First Patient Treated with SiPore21® Medical Device for Sustained Diabetes and Obesity Control
SiPore21® Silica "Molecular Sieves" Offer a Promising Non-Pharmaceutical Alternative SHINE Trial Marks a Milestone in Prediabetes and Weight Control Research STOCKHOLM, Oct. 9, 2023 /PRNewswire/ -- Sigrid Therapeutics announces the commencement of the SHINE clinical trial for SiPore21® –...

Hence then, the article about sigrid therapeutics announces first patient treated with sipore21 medical device for sustained diabetes and obesity control was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sigrid Therapeutics Announces First Patient Treated with SiPore21® Medical Device for Sustained Diabetes and Obesity Control )

Apple Storegoogle play

Last updated :

Also on site :